Clinical Trial Update: FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease [NA]

View source ↗

Summary

Clinical trial update on FGF-23 regulation in chronic kidney disease with results posted; focus on secondary hyperparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Snippet

Sponsor: University of California, Los Angeles | Conditions: Secondary Hyperparathyroidism | NA | Status: COMPLETED | Results posted: 2017-03-31